Genetic testing for cancer risk assessment: A review

Oncologist

Volumn 2, Issue 4, 1997, Pages 208-222

  Grogan, L ^a   Kirsch, L R ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL NAVAL MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Colorectal cancer; Genetic counseling; Genetic testing; Oncogenes; Tumor suppressor genes

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SUSCEPTIBILITY; COLON CANCER; COLON CARCINOGENESIS; FAMILIAL CANCER; GENE MUTATION; GENETIC COUNSELING; HUMAN; ONCOGENE; PRIORITY JOURNAL; RISK ASSESSMENT; TUMOR SUPPRESSOR GENE;

EID: 0030811259     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.2-4-208     Document Type: Article

References (19)

1. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility. Adopted on February 20, 1996. J Clin Oncol 1996;14:1730-1740.
2. Statement on use of DNA testing for presymptomatic identification of cancer risk. National Advisory Council for Human Genome Research. JAMA 1994;271:785.
3. Statement on informed consent for genetic research. The American Society of Human Genetics. Am J Hum Genet 1996;59:471-474.
4. Statement on genetic testing for breast and ovarian cancer predisposition. The American Society of Human Genetics Am J Hum Genet 1994;55:i-iv.
5. Kirsch IR. Oncogenesis. In: Oldham KT, Foglia RB, Colombani PM, eds. Surgery of Infants and Children: Principles and Practice. Philadelphia: Lippincott-Raven, 1996:549-567.
6. Bishop JM. Cancer: the rise of the genetic paradigm. Genes Dev 1995;9:1309-1315.
7. Rous PA. A sarcoma of the fowl transmissible by an agent seperable from the tumor cells. J Exp Med 1911;13:397.
8. Skuse GR, Ludlow JW. Tumour suppressor genes in disease and therapy. Lancet 1995;345:902-906.
9. Knudson AG, Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820-823.
10. Friend SH, Bernards R, Rogelj S et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986;323:643-646.
11. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-170.
12. Aaltonen LA, Peltomaki P, Leach FS et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-816.
13. Ionov Y, Peinado MA, Malkhosyan S et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonie carcinogenesis. Nature 1993;363:558-561.
14. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-819.
15. Modrich P. Mismatch repair, genetic stability and tumour avoidance. Philos Trans R Soc Lond B Biol Sci 1995;347:89-95.
16. Markowitz S, Wang J, Myeroff L et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 1995;268:1336-1338.
17. Parsons R, Li GM, Longley MJ et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 1993;75:1227-1236.
18. Marra G, Boland CR. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 1995;87:1114-1125.
19. Vaux DL, Haecker G, Strasser A. An evolutionary perspective on apoptosis. Cell 1994;76:777-779.